Retail Opportunity Investments Corp. Reports Strong 2015 Results
Feb 23, 2016 21:05 pm UTC| Business
12.9% Increase in FFO Per Share (19.0% Increase in 4Q) Establishes 2016 FFO Guidance Increases Cash Dividend by 5.9% SAN DIEGO, Feb. 23, 2016 -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today...
Revance to Participate in Upcoming Investor Conferences
Feb 23, 2016 21:05 pm UTC| Business
NEWARK, Calif., Feb. 23, 2016 -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today that...
Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 21:05 pm UTC| Business
EMERYVILLE, Calif., Feb. 23, 2016 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced financial results for the fourth quarter and full year ended December 31, 2015. Adamas reported a net loss attributable to...
Enphase Energy Reports Financial Results for the Fourth Quarter and Fiscal Year 2015
Feb 23, 2016 21:05 pm UTC| Business
PETALUMA, Calif., Feb. 23, 2016 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced today financial results for the fourth quarter and year ended December31, 2015. Enphase Energy...
Five9 Announces Revenue Growth of 27% and Positive Adjusted EBITDA for the Fourth Quarter of 2015
Feb 23, 2016 21:05 pm UTC| Business
Q4 LTM Enterprise Subscription Revenue Increased 38% Year-Over-Year Record Annual Revenue of $128.9 Million, Up 25% Year-Over-Year SAN RAMON, Calif., Feb. 23, 2016 -- Five9, Inc. (NASDAQ:FIVN), a leading provider...
BioBlast Pharma Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 21:05 pm UTC| Business
NEW HAVEN, Conn., Feb. 23, 2016 -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the fourth quarter and fiscal year ended...
Alder BioPharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
Feb 23, 2016 21:05 pm UTC| Business
Conference Call Today at 5 p.m. EST - ALD403 12-Week Phase 2b Chronic Migraine and Phase 1 Self-Administration Top-line Data Expected First Quarter 2016 - BOTHELL, Wash., Feb. 23, 2016 -- Alder BioPharmaceuticals,...